These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds. Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528 [TBL] [Abstract][Full Text] [Related]
3. Comparison of 2-mercaptopropionylglycine and D-penicillamine in the treatment of cystinuria. Harbar JA; Cusworth DC; Lawes LC; Wrong OM J Urol; 1986 Jul; 136(1):146-9. PubMed ID: 3712602 [TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria. Lindell A; Denneberg T; Jeppsson JO Nephron; 1995; 71(3):328-42. PubMed ID: 8569983 [TBL] [Abstract][Full Text] [Related]
5. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. Dolin DJ; Asplin JR; Flagel L; Grasso M; Goldfarb DS J Endourol; 2005 Apr; 19(3):429-32. PubMed ID: 15865542 [TBL] [Abstract][Full Text] [Related]
7. CYSTINURIA: EFFECT OF D-PENICILLAMINE ON PLASMA AND URINARY CYSTINE CONCENTRATIONS. CRAWHALL JC; THOMPSON CJ Science; 1965 Mar; 147(3664):1459-60. PubMed ID: 14263760 [TBL] [Abstract][Full Text] [Related]
8. Mercaptopropionylglycine: a progress in cystine stone therapy. Hautmann R; Terhorst B; Stuhlsatz HW; Lutzeyer W J Urol; 1977 May; 117(5):628-30. PubMed ID: 870714 [TBL] [Abstract][Full Text] [Related]
9. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. Pak CY; Fuller C; Sakhaee K; Zerwekh JE; Adams BV J Urol; 1986 Nov; 136(5):1003-8. PubMed ID: 3534301 [TBL] [Abstract][Full Text] [Related]
10. Investigations of the efficacy of ascorbic acid therapy in cystinuria. Birwé H; Schneeberger W; Hesse A Urol Res; 1991; 19(3):199-201. PubMed ID: 1887529 [TBL] [Abstract][Full Text] [Related]
11. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria. Parvex P; Rozen R; Dziarmaga A; Goodyer P Mol Genet Metab; 2003 Dec; 80(4):419-25. PubMed ID: 14654355 [TBL] [Abstract][Full Text] [Related]
12. [Results of treatment of cystinuria and cystine lithiasis with alpha-mercaptopropionylglycine. Apropos of 40 patients]. Giannakopoulos X; Kalfakakou V; Tsoumanis P; Karkabounas S; Giannakis D; Chambilomatis P; Evangelou A; Kallistratos G J Urol (Paris); 1994; 100(3):129-34. PubMed ID: 7836789 [TBL] [Abstract][Full Text] [Related]
13. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference. Nakagawa Y; Coe FL Clin Chim Acta; 1999 Nov; 289(1-2):57-68. PubMed ID: 10556653 [TBL] [Abstract][Full Text] [Related]
14. [A semiquantitative rapid test for cysteine: possible use for monitoring the ascorbic acid therapy in cystinuria and cystine lithiasis]. Berg W; Kilian O J Clin Chem Clin Biochem; 1988 Apr; 26(4):223-7. PubMed ID: 3404089 [TBL] [Abstract][Full Text] [Related]
15. The long-term outcome of cystinuria in Japan. Akakura K; Egoshi K; Ueda T; Nozumi K; Kotake T; Masai M; Ito H Urol Int; 1998; 61(2):86-9. PubMed ID: 9873246 [TBL] [Abstract][Full Text] [Related]
16. The effect of sodium intake on cystinuria with and without tiopronin treatment. Lindell A; Denneberg T; Edholm E; Jeppsson JO Nephron; 1995; 71(4):407-15. PubMed ID: 8587620 [TBL] [Abstract][Full Text] [Related]
17. [Results of long-term treatment of cystine lithiasis with D-penicillamine]. Bec P; Lacombe JL; Malha F; Pujo JM Nephrologie; 1984; 5(5):228-31. PubMed ID: 6531062 [TBL] [Abstract][Full Text] [Related]